INTRACELLULAR CALCIUM LEVELS ARE DIFFERENTIALLY REGULATED IN T-LYMPHOCYTES TRIGGERED BY ANTI-CD2 AND ANTI-CD3 MONOCLONAL-ANTIBODIES

被引:7
|
作者
SPINOZZI, F
AGEA, E
BISTONI, O
BELIA, S
TRAVETTI, A
GERLI, R
MUSCAT, C
BERTOTTO, A
机构
[1] UNIV PERUGIA,DEPT INTERNAL MED,I-06100 PERUGIA,ITALY
[2] UNIV PERUGIA,DEPT CELLULAR BIOL,I-06100 PERUGIA,ITALY
[3] UNIV PERUGIA,DEPT PEDIAT,I-06100 PERUGIA,ITALY
关键词
INTRACELLULAR CALCIUM CD3 AND CD2 STIMULATION; T LYMPHOCYTES; JURKAT T CELLS; IP3; GENERATION; CA2+/MG2+ ATPASE;
D O I
10.1016/0898-6568(94)00079-Q
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antigen and/or mitogen-driven T-cell activation is mediated by a rise in intracellular free Ca2+, as second messenger. A regulatory key role for this process is represented by membrane-associated [Ca2+/Mg2+] ATP-ase that is mainly devoted to extrusion of intracellular ion excess. In the present study we have investigated the kinetics of Ca2+ fluxes in both resting and already activated (Jurkat T-cell line) T lymphocytes after CD3 and CD2 (T11(2) and T11(3)) triggering and focused our attention on plasma membrane [Ca2+/Mg2+] ATP-ase activity. In both resting T cells and Jurkat cell line, the CD2 stimulation was able to determine a rise in intracellular free Ca2+ higher than that observed after CD3 triggering. In addition, this calcium signal was independent of negative feedback control exerted by [Ca2+/Mg2+] ATP-ase, as well as of IP3 generation. Thus the CD2 molecular system may, together with cell-adhesion properties, act as an amplifier of Ca2+ signals that, if delivered in the context of other molecular systems, such as CD3 or MHC class II antigens, are essentially devoted to the polyclonal co-stimulatory recruitment of a larger cellular repertoire.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 50 条
  • [1] ACTIVATION OF RAT LYMPHOCYTES-T BY ANTI-CD2 MONOCLONAL-ANTIBODIES
    CLARK, SJ
    LAW, DA
    PATERSON, DJ
    PUKLAVEC, M
    WILLIAMS, AF
    JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06): : 1861 - 1872
  • [2] CYTOSOLIC-FREE CALCIUM-CONCENTRATION IN THE MITOGENIC STIMULATION OF T-LYMPHOCYTES BY ANTI-CD3 MONOCLONAL-ANTIBODIES
    MURGIA, M
    MION, M
    VERONESE, L
    PANOZZO, M
    COPPOLA, V
    RIZZUTO, R
    BRINI, M
    MALAVASI, F
    AMADORI, A
    BIANCHI, LC
    POZZAN, T
    CELL CALCIUM, 1994, 16 (03) : 167 - 180
  • [3] ANTI-CD2 MONOCLONAL-ANTIBODIES SYNERGIZE WITH ANTI-CD3 TO PROLONG ALLOGRAFT SURVIVAL AND DECREASE CYTOKINE PRODUCTION
    CHAVIN, KD
    QIN, L
    LIN, J
    KAPLAN, AJ
    BROMBERG, JS
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 823 - 824
  • [4] ANTI-CD2 MONOCLONAL-ANTIBODIES INHIBIT CYTOTOXIC T LYMPHOCYTES INVIVO AND INVITRO
    BROMBERG, JS
    CHAVIN, KD
    FASEB JOURNAL, 1992, 6 (05): : A2006 - A2006
  • [5] NEPHROTOXICITY OF ANTI-CD3 MONOCLONAL-ANTIBODIES
    ALEGRE, ML
    DEPIERREUX, M
    FLORQUIN, S
    ABRAMOWICZ, D
    DEPAUW, L
    KINNAERT, P
    VEREERSTRAETEN, P
    GOLDMAN, M
    NEPHROLOGIE, 1991, 12 (01): : 42 - 45
  • [6] ANTI-CD2 AND ANTI-CD3 MONOCLONAL-ANTIBODIES SYNERGIZE TO PROLONG ALLOGRAFT SURVIVAL WITH DECREASED SIDE-EFFECTS
    CHAVIN, KD
    QIN, LH
    LIN, JX
    KAPLAN, AJ
    BROMBERG, JS
    TRANSPLANTATION, 1993, 55 (04) : 901 - 908
  • [7] ACTIVATION OF HUMAN LYMPHOCYTES-T BY CROSSLINKING OF ANTI-CD3 MONOCLONAL-ANTIBODIES
    DIXON, JFP
    LAW, JL
    FAVERO, JJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 46 (03) : 214 - 220
  • [8] ANTI-CD3 MONOCLONAL-ANTIBODIES - CHARACTERIZATION AND FUNCTIONS
    BOUREL, D
    GENETET, N
    MERDRIGNAC, G
    GENETET, B
    PATHOLOGIE BIOLOGIE, 1987, 35 (10): : 1285 - 1291
  • [9] DIFFERENTIAL IMMUNOMODULATION BY ANTI-CD2 MONOCLONAL-ANTIBODIES OF ANTI-CD3-INDUCED T-CELL ACTIVATION - DEPENDENCE UPON THE INDIVIDUAL ANTI-CD3 MONOCLONAL-ANTIBODY USED FOR ACTIVATION
    STOHL, W
    POSNETT, DN
    CHIORAZZI, N
    CELLULAR IMMUNOLOGY, 1988, 116 (01) : 73 - 85
  • [10] COMBINED ANTI-CD2 AND ANTI-CD3 RECEPTOR MONOCLONAL-ANTIBODIES INDUCE DONOR-SPECIFIC TOLERANCE IN A CARDIAC TRANSPLANT MODEL
    CHAVIN, KD
    QIN, LH
    LIN, JX
    YAGITA, H
    BROMBERG, JS
    JOURNAL OF IMMUNOLOGY, 1993, 151 (12): : 7249 - 7259